TYNDALL CAPITAL PARTNERS L P

Latest 13F filing data - Q2 2025

Holdings

(Top positions)

STOCK	TICKER	SHARES HELD▲ ▼	VALUE▲ ▼
Cyclerion Therapeutics, Inc.	CYCN	155.19K	$451.59M